Izvorni znanstveni članak

Quality of Life in Patients with Blepharospasm

Dubravka Biuk ; »J. J. Strossmayer« University, Osijek University Hospital Center, Department of Ophthalmology, Osijek, Croatia
Anita Alegic Karin ; University of Zagreb, Dubrava University Hospital, Dapartment of Psychiatry, Referral Centre for Stress Related Disorders and
Suzana Matic ; »J. J. Strossmayer« University, Osijek University Hospital Center, Department of Ophthalmology, Osijek, Croatia
Josip Barac ; »J. J. Strossmayer« University, Osijek University Hospital Center, Department of Ophthalmology, Osijek, Croatia
Tvrtka Benasic ; »J. J. Strossmayer« University, Osijek University Hospital Center, Department of Ophthalmology, Osijek, Croatia
Neda Stiglmayer ; University of Zagreb, Zagreb University Hospital Center, Department of Ophthalmology, Zagreb, Croatia

Sažetak

The aim of this prospective study was to analyse the quality of life in patients with blepharospasm grade III and IV and to explore whether Botulinum neurotoxin type A treatment improves their quality of life.We used a WHOQOL-BREF questionnaire, based on the existing WHO recommendation and its meaningful metric characteristics. The study included 37 patients with either grade/type III or IV blepharospasm who were treated with Botulinum neurotoxin Type A. Each patient completed the WHOQOL-BREF questionnaire by themselves just before the Botulinum Neurotoxin Type A (BT-A) therapy application, when the cilinical symptoms of blepharospasm were most manifest and a month and a half after, when the regression of symptoms appeare. Consequently, the application of BT-A resulted in improved changes in terms of quality of life in 3 of the 4 measured fields (psychical and physical health as well as the environmental living conditions).

Ključne riječi

blepharospasm; Botulinum neurotoxin Type A; WHOQOL-BREF; quality of life

Hrčak ID:

99505

URI

https://hrcak.srce.hr/99505

Datum izdavanja:

3.4.2013.

Posjeta: 1.526 *